CLINICAL_TRIALS
trial_result
· 2011-02-25
Clinical Trial Update: Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout [Phase 3]
Summary
Phase 3 trial update reporting safety and efficacy results for PEG-uricase (pegloticase) in hyperuricemic patients with symptomatic gout; results posted in 2011…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Savient Pharmaceuticals | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2011-02-25